This algorithm was developed from the one proposed by Caputo et al.4 (“Algorithm 1”) by adding further codes for specific laboratory exams, such as the codes for somatotropic hormone measurement and IGF-1 levels measurement, and searching for acromegaly-specific co-payment exemptions also using ICD-9 codes. This evidence concerns the gene IGF1 and acromegaly.